Allen S Mandir

Title: Allen S Mandir: Innovator in Neurotoxicity Treatment

Introduction

Allen S Mandir is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of neurotoxicity treatment through his innovative research and patent.

Latest Patents

Allen S Mandir holds a patent for a method of using selective PARP inhibitors to prevent or treat neurotoxicity. This patent addresses neutral tissue damage resulting from ischemia and reperfusion injury or neurodegenerative diseases. The invention involves administering therapeutically effective amounts of certain selective inhibitors of poly(ADP-ribose) polymerase. These inhibitors can be delivered through various methods, including intravenous, intraperitoneal, intramuscular, intraventricular, or oral administration. They can be provided in the form of capsules or tablets containing single or divided doses, or as a sterile solution, suspension, or emulsion.

Career Highlights

Allen S Mandir is affiliated with The Johns Hopkins University, where he continues to advance his research in neurotoxicity and related fields. His work has the potential to significantly impact the treatment of neurodegenerative diseases.

Collaborations

Some of his notable coworkers include Mikael J Eliasson and Kenji Sampei, who have collaborated with him on various research projects.

Conclusion

Allen S Mandir's innovative approach to treating neurotoxicity through selective PARP inhibitors showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic options in the field of neurodegenerative diseases.